TriSalus Life Sciences, Inc. (TLSI) Insider Trading Disclosures
TriSalus Life Sciences, Inc. (TLSI) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TLSI
CIK: 1826667
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDaniel Voogt
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065326 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065325 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065324 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065323 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001628280-26-063031 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-054275 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-054264 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-07 | — | SCHEDULE 13G/A Filing | 0001999371-26-014465 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0001628280-26-047217 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001628280-26-046519 | View SEC Doc Filr Page |
| 5 | 2026-07-01 | 2025-12-31 | FORM 5 | 0001628280-26-046511 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001628280-26-046507 | View SEC Doc Filr Page |
| 5 | 2026-07-01 | 2025-12-31 | FORM 5 | 0001628280-26-046501 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-29 | FORM 4 | 0001628280-26-046015 | View SEC Doc Filr Page |
| 3 | 2026-06-29 | 2026-06-29 | FORM 3 | 0001628280-26-046011 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-20 | — | SCHEDULE 13G/A Filing | 0001104659-26-064507 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-15 | FORM 4 | 0001628280-26-036427 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | FORM 4 | 0001628280-26-035996 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | FORM 4 | 0001628280-26-035995 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | FORM 4 | 0001628280-26-035994 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | FORM 4 | 0001628280-26-035992 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | FORM 4 | 0001628280-26-035991 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001999371-26-010893 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-14 | FORM 4 | 0001628280-26-035669 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-14 | FORM 4 | 0001628280-26-035667 | View SEC Doc Filr Page |